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ABSTRACT 
The objective of this research was to search for an antiviral compound, 
garcinol (or guttiferone F) from the Garcinia kola nuts using two different extraction 
techniques and formulate a suitable liposome for control release using an antiviral 
compound.  The two extraction techniques used were: liquid-liquid extraction (for 
simplicity purposes, the term solvent-solvent, S-S, will be used interchangeable) and 
Supercritical Fluid Extraction (SFE).  Both techniques were used to profile 
compounds found in Garcinia kola and for statistical comparison purposes.  Extracts 
from both techniques were collected and analyzed for separation using Reversed-
Phase High Performance Liquid Chromatography (RP-HPLC) using Ultraviolet 
Photodiode Array (UV-PDA) detection, determined physical and chemical properties 
by proton and phosphorus Nuclear Magnetic Resonance (
1H
NMR and 
31
P-NMR), and 
quantify by Ultra Performance Convergence Chromatography (UPC
2
) coupled to 
Quadrupole Time of Flight Mass Spectroscopy (Q-ToF/MS).  The UPC
2
 Q-ToF/MS 
data was processed using TransOmics Informatics for Metabolomics and Lipidomics 
(TOIML) and statistical analysis was performed interrogating similarities and 
dissimilarities of each extraction techniques.  Biological assay were conducted on 
three of the S-S extracts and compared to know antiviral inhibiting drugs as controls.  
For the formulation study, Dynamic Light Scattering (DLS), Differential Scanning 
Calorimetry (DSC) and release studies were conducted in order to characterize the 
garcinol liposomes.  Initial RP-HPLC results showed no compounds with photodiode 
array (PDA) fingerprints characteristic of garcinol were found in either of the extracts 
from both extraction techniques.  NMR confirmed what was already observed: 
  
 
garcinol has the same molecular formula, weight and chemical structure as the 
previously reported guttiferone F and both names (garcinol and guttiferone F) are used 
interchangeable. Comparison of the different extraction techniques by UPC
2
 Q-
ToF/MS resulted in the identification of 1291 chemical features and the features were 
grouped together statistically based on their relative extraction solvents and 
techniques.  Of the 1291 detectable mass constituents, 43.81% can be extracted by S-S 
technique and 40.09% can be extracted by SFE technique, relatively similar extraction 
profile.  Approximately 20.99% of the mass constituents were detected using both 
extraction techniques.  Overall, results from the SFE showed the comprehensive 
profile of all mass constituents found within this natural product and each mass 
grouped statistically based on their relative extraction solvents to determine extraction 
coverage.  In addition, these statistical analysis and extraction techniques have never 
been performed simultaneously and or compared on Garcinia kola seeds.  Biological 
data revealed that extracts from the S-S technique was negative for the inhabitation of 
antiviral activities as compare to the controls.  The results of the liposome release 
studies indicated initial rapid release of less than 1% of garcinol from the liposomes, 
followed by a sharp drop in concentration at 4 hours, suggesting precipitation in the 
dissolution medium with no further release as the concentration leveled off to 140 
hours.  DSC results indicated that the surface charge of the liposome was -10.5 mV 
and remained relatively constant for 7 days suggesting stability issues.  DLS results 
indicated an increase in particle size and Polydispersity index over a 7 day period 
which also suggests stability issues. Overall, the formulation study showed garcinol 
released less than 1% and may interact significantly with the DPPC phosphate head 
  
 
groups, as indicated by the large increase in net negative surface charge.  Although no 
antiviral activities were active in Garcinia kola, this edible plant could serve as an 
abundant source of naturally-occurring, bioactive compounds for further 
pharmaceutical development for other biological activities.   
 
 
 
 
 
 
 v 
 
ACKNOWLEDGEMENTS 
 
I’d like to thank my Lord and Savior Jesus Christ for being the head of my life 
and providing the necessary resources to complete this research project.  I’d like to 
thank my major advisor Dr. David Worthen for going above and beyond in believing 
in and supporting me throughout graduate school.  I cannot thank him enough!  Next 
my aunt, Elizabeth “Poor Girl” Duncan for her words of wisdom about traditional 
Liberian plants and igniting the fire that gave birth to this research project.  I could not 
have successfully finished this research project without the Natural Products team at 
Waters Corporation in Milford, Massachusetts especially Michael Jones, Dr. Giorgis 
Isaac and Dr. Dustin Yaworsky who took the time out of their busy schedules to 
training, mentoring, and provide access to their analytical laboratory.  Working with 
them truly helped take the research project to another level.  I’d also like to express 
my deepest gratitude to Dr. Henry Genieva for all of her guidance on the isolation 
portion of this research.  Many thanks to the Raga Institute for Medical Research 
especially Dr. Christophe Pannecouque and Dr. Pieter Leyssen for the biological assay 
work. I’d also like to thank my mentor Charles “Chuck” Watson in the College of 
Engineering Dean’s Office for all of his support and encouragement throughout 
graduate school. And lastly I’d like to thank my natural and spiritual family and 
friends for their unconditional love, support, encouragement and prayers: truly without 
all of the names mentioned above, my project wouldn’t have been a success. Ma God 
bless everyone of you! 
 
 
 vi 
 
TABLE OF CONTENTS 
ABSTRACT .................................................................................................................. ii 
ACKNOWLEDGEMENTS ......................................................................................... v 
LIST OF CONTENT .................................................................................................. vi 
LIST OF TABLES ...................................................................................................... ix 
LIST OF GRAPHS ...................................................................................................... x 
LIST OF FIGURES ................................................................................................... xii 
CHAPTER 1 INTRODUCTION ................................................................................ 1 
CHAPTER 2 REVIEW OF LITERATURE ............................................................. 6 
2.1 Antiviral properties found in Garcinia genus ...................................................... 6 
2.2 Natural product development ............................................................................... 7 
2.3 Pharmaceutical formulation in Garcinia kola and Garcinia spp. ....................... 9 
2.4 Extraction technique overview ........................................................................... 13 
2.4.1 Liquid-liquid extraction ................................................................................... 14 
2.4.2 Supercritical fluid extraction (SFE) ................................................................ 15 
CHAPTER 3 METHODOLOGY ............................................................................. 18 
3.1 Materials ............................................................................................................... 18 
3.2 Extraciton techiques ............................................................................................ 19 
3.2.1 Liquid-liquid extraction ................................................................................... 19 
3.2.2 Supercritcal fluid extraction ............................................................................ 21 
3.3 Analytical analysis ................................................................................................ 21 
3.3.1 Reverse-Phase High Performance Liquid Chromatography (RP-HPLC) .. 21 
 vii 
 
3.3.2 Ultra Performance Convergence Chromatography (UPC
2
) coupled to 
Quadrupole Time-of-Flight Mass Spectroscopy (Q-Tof-MS) ................................ 22 
3.3.3 Nuclear Magnetic Resonance (
1H
NMR and 
31
P-NMR) .................................. 25 
3.4 Biological Assay .................................................................................................... 27 
3.5 Preparation of liposome formulation ................................................................. 28 
3.5.1 Sonication ........................................................................................................... 29 
3.5.2 nano Differential Scanning Calorimetry (nano-DSC) ................................... 29 
3.5.3 Zeta potential ..................................................................................................... 31 
3.5.4 Dynamic light scattering (DLS) ....................................................................... 33 
3.5.5 Dialysis ............................................................................................................... 34 
3.5.6 Disolution ........................................................................................................... 34 
CHAPTER 4 RESULTS AND DISCUSSION ......................................................... 36 
4.1 Liquid-liquid extraction results .......................................................................... 36 
4.2 Supercritcal fluid extraction (SFE) results ........................................................ 37 
4.3 Comparison of both extraction techniques ........................................................ 38 
4.4 Biological study .................................................................................................... 46 
4.5 Garcinol fomulation study ................................................................................... 47 
4.5.1 Zeta potential ..................................................................................................... 47 
4.5.2 Dynamic ligth scattering (DLS) results ........................................................... 48 
4.5.3 nano Differential scanning calorimetry (nano-DSC) results ......................... 50 
4.5.4 Nuclear magnetic resonance (
1H
NMR and 
31
P-NMR) results ....................... 51 
4.5.5 Formulaiton study ............................................................................................. 54 
CHAPTER 5 CONCLUSION ................................................................................... 62 
 viii 
 
BIBLIOGRAPHY ...................................................................................................... 65 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 ix 
 
LIST OF TABLES 
TABLE                 PAGE 
 
Table 1: Antiviral assay sample 28 
Table 2: Antiviral study of Garcinia kola extract (1:1 methylene chloride/methanol-
methanol, 1:1 methylene chloride/methanol-hexane, and MTB) versus controls 
(Nevirapine, Lamivudine, Azidothymidine, and Didecoyinosine) 47 
Table 3: 
1H
NMR chemical shift comparison of Garcinol and Fuller et al 1999 
Guttiferone F 52  
 
 
 
 
 
 x 
 
LIST OF GRAPHS 
GRAPH                 PAGE 
Graph 1: Breakdown of the total features found in solvent-solvent (S-S) and 
Supercritical fluid extraction (SFE) determined by a normalized abundance .1% based 
on the TOIML dendrogram data set 41 
Graph 2: Percentage breakdown of the total features found in S-S extracts as observed.
 41 
Graph 3: Percentage breakdown of the total features found in SFE extracts as 
observed. 42 
Graph 4: Garcinol (bottom) in comparison to other solvent-solvent extracts 
chloroform, Sephadex 3/4, hexane, MTB, ethyl acetate, respectfully. Results indicate 
no presence of Garcinol in any S-S fraction. 42 
Graph 5: UPC
2
/MS
E
 ES
–
 BPI MS traces of the IPA (30%, 10%, and 5%) SFE and 
100% CO2 extractions from the top to the bottom.  Garcinol was not observed to be 
present in these or any of the other SFE extractions with MeOH and EtOH. 43 
Graph 6: UPC
2
/MS
E
 ES
–
 BPI MS traces of the Methanol (30%, 10%, and 5%) SFE 
and 100% CO2 extractions from the top to the bottom.  Garcinol was not observed to 
be present in these or any of the other SFE extractions with IPA and EtOH. 43 
Graph 7: The results of surface charge through Zeta potential measurements. 48  
Graph 8: Garcinol particle size results. 49  
Graph 9: Garcinol Polydispersity index results. 50 
Graph 10: Results of phase transitions through DSC measurements of blank DPPC 
liposomes and garcinol DPPC liposomes. 50 
 xi 
 
Graph 11:
 1H
NMR spectrum of garcinol in red and hexane extract in black. 53 
Graph 12: Phosphorus NMR results of: (a) blank DPPC liposomes versus (b) garcinol 
DPPC liposome. 53 
Graph 13: Garcinol calibration curve with 50 mM Potassium Phosphate solution. 60  
Graph 14: Garcinol dialysis release study. 60  
Graph 15: Garcinol dissolution release study. 61 
 
 xii 
 
LIST OF FIGURES 
FIGURE                 PAGE 
Figure 1: General structure of polyisoprenylated benzophenones Acuna et al 2009. 2 
Figure 2: Garcinia kola seeds (courtesy of Google image). 3 
Figure 3: The structure of bioflavonoids: Kolaviron (courtesy of Google image). 3 
Figure 4: Small molecules new entities 1981-2008 by Newman et al. 2003. 8 
Figure 5: FDA approved new molecule entities 1998-2012 (courtesy of FDA.com). 9 
Figure 6: Separatory funnel (courtesy of Google image). 15 
Figure 7: Phase diagram of Carbon dioxide, CO2 (courtesy of Google image). 16 
Figure 8: Supercritical Fluid Extraction system (courtesy of Waters Coroporaiton). 17 
Figure 9: Flow chart of Guttiferone F isolation (Fuller et al. 1999). 21 
Figure 10: Workflow overview analysis (courtesy of Waters Corporation). 25 
Figure 11: The structure of 1,2-Dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) 
(courtesy of Google image). 30 
Figure 12: Zeta potential definition (courtesy of Google image). 32 
Figure 13: HPLC chromatogram overlaid of each solvent-solvent extraction sample 
(methanol, MTB, Sephadex 3/4, hexane, ethyl acetate, chloroform extracts) and the 
injection of Garcinol standard using 80:20 (w/w) acetonitrile-water mobile phase. 36  
Figure 14: HPLC overlaid chromatograms of the SFE extractions and the injection of 
the Garcinol standard. 38  
Figure 15: Trend plot of solvent-solvent and SFE samples as determined by principle 
component analysis (PCA). 39 
Figure 16: TOIML dendrogram data and abundance plot of a single feature (RT 
 xiii 
 
1.05min; m/z=499.2848) found in both 5% EtOH (left) and Sephadex fraction 3/4 
(right). 40
Figure 17: Garcinol MS
E 
data at high and low collision energy with BPI trace.
 45 
Figure 18: MS
E
 precursor and product ion data: major fragment used to confirm the 
presence of Garcinol. 45 
Figure 19: 137 mM Phosphate buffer solution initial. 54 
Figure 20: 137 mM Phosphate buffer solution 19 hours. 55 
Figure 21: 137 mM Phosphate buffer solution 44 hours. 55 
Figure 22: 5 mM Sodium chloride initial. 55 
Figure 23: 5 mM Sodium chloride 31 hours. 56 
Figure 24: 5 mM Tris initial. 56 
Figure 25: 5 mM Tris 31 hours. 57 
Figure 26: 5 mM Sodium citrate initial. 57 
Figure 27: 5 mM Sodium citrate 32 hours. 58 
Figure 28: 50 mM Potassium phosphate. 58 
Figure 29: 50 mM Potassium phosphate 85 hours. 59
 1 
 
CHAPTER 1 
 
INTRODUCTION 
Garcinia kola is a species of flowering plants which grows in tropical climates 
across Western Africa, Asia, and Australia. Garcinia kola belongs to the Guttiferae 
(formally Clusiaceae) family.  There are more than thirty genera of Guttiferae, 
including Calophyllum, Hypericum, Allanblackia, and Garcinia. (Whitmore et al., 
1973).  Guttiferae is divided into three subfamilies: Kielmeyeroideae; Hypericoideae; 
and Clusioideae
 
(Gustafsson et al., 2002). Garcinia belongs to the subfamily 
Clusioideae. There are well over fifty species of evergreen trees and shrubs belonging 
to the Garcinia genus, including Garcinia cambogia, Garcinia indica, Garcinia 
mangostana, Garcinia livingstonei, Garcinia candelliana and Garcinia kola. (Smith 
et. al., 2004).  Known products containing Garcinia mangostana are commonly sold 
as dietary supplements in the United States under the trade name Hydroxycut 
TM
.   
There are four main classes of secondary metabolites with biological activities 
found in the Guttiferae family: benzophenones; bioflavonoids; coumarins; and 
xanthones.  The chemical structures of several of the benzophenones contain the 
polyisoprenylated benzophenone core bicyclo [3.3.1]-nonane-2, 4, 9-trione linked to a 
13, 14-dihydroxybenzoyl phenyl ring is found in Figure 1 (McCandish et al., 1976). 
 
This core structure is a common structural motif of the benzophenones which have 
been isolated from plants.  The benzophenones are increased in hydrophobicity per 
number of prenyl functional groups attached.    
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Garcinia kola has a distinct bitter taste-hence its common name “bitter kola” 
and also its common name “male kola” because of its claimed aphrodisiac activity.    
There is an average of four seeds contained in a fruit (Figure 2). The seeds are 
extracted by breaking open the fruit. The seed contains fat, proteins, carbohydrates, 
xanthones, bioflavonoids, benzophenones, and other compounds.  They are chewed 
for the relief of cough, colds, colic, hoarseness of voice, and throat infection (Ofokansi 
et al., 2008).  The fruit pulp is used to treat jaundice (Uko et al., 2001).  The sap is 
used for the treatment of parasitic skin diseases, while the latex is orally ingested for 
the treatment of gonorrhea (Ofokansi et al., 2008) and applied to wounds to assist in 
healing (Uko et al., 2001). The roots and stems are eaten as a snack food known as a 
chewing stick for dental care, to suppress appetite and to aid in the digestion process. 
Compounds isolated from Garcinia kola and other members of the Garcinia 
genus have been shown to have useful therapeutic, bio-protective, and other biological 
activities. Garcinia kola is used for the treatment of liver disorders (Adaramoye et al., 
2006). More recently, Garcinia kola has been assessed for its potential utility for 
fighting infectious viral diseases, such as Ebola, by preventing viral replication (BBC 
Health News, 1999).  Despite its bitter taste, Garcinia kola has been traditionally 
consumed for cultural, social, and traditional ceremonies, and for the worship of 
Figure 1: General structure of 
polyisoprenylated benzophenones (Acuna 
et. at. 2009) 
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ancestral gods.  Garcinia kola has also been employed as a substitute for hops in 
tropical beer (Ajebesone et al, 2004).  Paradoxically, it has been claimed to cause both 
nervous alertness and to induce insomnia (Uko et al., 2001). Thus, there is significant 
ethnobotanical and epidemiological evidence available suggesting that Garcinia kola 
is relatively non-toxic to humans when ingested or applied to the body.   
 
 
 
 
 
The most abundant biologically active constituent in the seed of Garcinia kola 
is known as kolaviron (Figure 3).  Kolaviron is a mixed biflavoniod complex derived 
from the defatted alcoholic extract of the plant. The complex consists of GB-1, GB-2, 
and kolaflavanone) shown below in Figure 3 (Cotterill et al., 1978).  The primary 
difference between GB-1 and GB-2 is the replacement of hydrogen (H) with a 
hydroxyl group (OH).    
  
 
 
 
 
 
 
 
Figure 3: The structure of bioflavonoids: Kolaviron (courtesy of Google image) 
Figure 2: Garcinia kola seeds (courtesy 
of Google image) 
 4 
 
 
Earlier work on the phytochemistry of Garcinia species resulted in the 
isolation of pharmacological compounds from several chemical classes including 
xanthones, bioflavonoids, triterpenes and benzophenones.  Xanthones are polyphenols 
that arise from the biosynthetic pathways of shikimate and acetate. A number of 
xanthones are known for their anti-cancer and anti-obesity properties (Iwu et al., 
1987).  The fruit hull of Garcinia mangostana possesses anti-cancer activity and this 
biological effect has been attributed to xanthones.  Xanthones are believed to act by 
blocking inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) 
expression (Wan et al., 2004).
 
Xanthones also possess anti-inflammatory activities 
(Chen et al., 2008) by the reduction of iNOS in murine macrophages. 
 
Bioflavoniods 
are phenolics, a class of phytochemicals which primarily act as plant pigments and 
possess antioxidant activities. Bioflavonoids have been isolated from the Garcinia 
kola and are abundant in the seeds of the plant (Faromi et al., 2011).  Triterpenes are 
compounds comprising six isoprene units which are also precursors of steroids.  
Triterpenes are found in the root bark of Garcinia polyantha and they possess 
antimalarial properties (Lannang et al., 2008). Benzophenones are ketone molecules 
used in perfume and medicine. Kolanone is a prenylated (addition of a hydrophobic 
prenyl moiety) benzophenone isolated from Garcinia kola possessing antimicrobial 
properties (Hussain et al., 1982).  These chemical classes are important and they may 
play a role in modulating various molecular metabolic pathways essential to human 
life.  They also show the diverse functions that this natural product possesses, 
suggesting many potential therapeutic and biological applications for Garcinia kola. 
 5 
 
The central objective of this study is to compare two different extraction 
techniques for the isolation, identification and conduct a pharmaceutical formulation 
of a potential antiviral compound responsible for inhibiting viral replication from 
Garcinia kola.  Although there is evidence that such isolation methods can be applied 
to isolate potential benzophenone antiviral compounds from related plant genera, these 
particular methods have not been applied to Garcinia kola.  In order to accomplish 
this, the following hypotheses are made:  
1. Utilize liquid-liquid extraction technique of Fuller et al.1999 for the isolation 
of antiviral compound Guttiferone F (also called Garcinol) found in the 
rootwood of Allanblackia stuhlmannii and applying the same extraction 
technique to Garcinia kola nuts could lead to the isolation of the same 
antiviral compound. In addition, profile the compounds found in this 
extraction technique.    
2. Utilize a second extraction technique, Supercritical Fluid Extraction (SFE) on 
Garcinia kola nuts for the isolation of antiviral compound Guttiferone F (also 
called Garcinol). In addition, profile the compounds found in this extraction 
technique and compare both extraction techniques. 
3. Formulate a representative antiviral compound into suitable liposomes for 
controlled drug release.  
The advantage of using both extraction techniques is to obtain a wide range of 
extracted compounds found in Garcinia kola and for comparison purposes.  
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CHAPTER 2 
 
REVIEW OF THE LITERATURE 
 
This chapter will focus on the literature related to the published biological 
activities, formulation studies conducted on Garcinia kola and other Garcinia spp as 
well as two separation techniques used in the pharmaceutical industry: liquid-liquid 
extraction and Supercritical Fluid Extraction (SFE). 
2.1 Antiviral properties found in the Garcinia family 
There are various species in the Garcinia genus which are reported to possess 
antiviral properties.  These species include Garcinia livingstonei, Garcinia ovalifolia 
(Gustafson et al., 1992), and Garcinia mangosteen (Chen et al., 1996), among others. 
The compounds responsible for the antiviral properties have been identified as 
guttiferones.  Guttiferones are polyisoprenylated benzophenone derivatives that inhibit 
by cytopathic effects the activity of the virus responsible for HIV infection (Gustafson 
et al., 1992).  Most polyprenylated benzophenones isolated from these plants also 
contain carbonyl, hydroxyl and other polar groups.    
Perhaps the most cited naturally-occurring, Garcinia-derived benzophenone in 
the literature is camboginol, also a synonym for garcinol.  Garcinol is a 
polyisoprenylated benzophenone which has been recovered from Garcinia assigu, (Ito 
et al., 2003) Garcinia indica (Hong et al., 2007), Garcinia purpurea (Matsumoto et 
al., 2003), Garcinia banacana (Rukachaisirikul et al., 2005), Moronobea coccinea 
(Marti et al., 2008), and Allenblackia monticola (Lenta et al., 2007) and assayed for 
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cytotoxicity as well as anti-bacterial, anti-viral, and anti-parasitic activities.  Garcinol 
has the same or even very similar structural to that of Guttiferone F (Gustafson et al., 
1992) and the names are said to be used interchangeable (Fuller et. al., 1999).  
Guttiferone and related benzophenone antiviral compounds have been reported to be 
isolated from Garcinia kola and other Garcinia spp. and they contain a number of 
valuable biological active compounds.  However, relatively few studies have been 
reported describing the design and performance of Garcinia derived formulations and 
drug delivery systems on its proposed antiviral properties.  Accordingly, another goal 
of this work is to develop a pharmaceutical formulation for the controlled delivery of a 
benzophenone antiviral compound.   
2.2 Natural Product Development 
According to Newman et al. in “Natural Products as Sources of New Drugs 
over the Period 1981-2002”, over 70% of small molecule drugs on the market are 
derived from or are based on natural product sources (Figure 4). Natural product 
sources listed includes: Unmodified Natural Products (N), Natural Product Derived 
(ND), Natural Product Mimic (NM), Biological (B), and Total Synthesis (S*).  
Though there are numerous compounds isolated from natural products, formulating 
them into effective dosage form is a challenging process due to the lack of 
standardization, as well as poor solubility and limited chemical and metabolic 
stability.  An increase in the study of components in the Garcinia genus has risen 
within the past 20 years, but there have only been a few investigations conducted in 
the United States and few-if any- on the isolation and formulation of compounds 
purported to be responsible for their antiviral properties. Thus far, the only 
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formulation studies performed on Garcinia kola focus on the formulation of the main 
constituent, kolaviron. To date, there are only two FDA approved drugs derived from 
botanical preparation: Veregen which is a topical green tea extract approved in 2006 
for the treatment of genital warts, and Fulyzaq (Crofelemer) an orally administered 
drug approved in December 2012 for the treatment of HIV-associated diarrhea. This 
implies that out of the 39 FDA approved new molecular entities in 2012, only 1 of 
which is for HIV related diseases (Figure 5). Exploring this novel area of the 
pharmaceutical potential of Garcinia kola may result in additional approved products 
for the palliation and treatment of various pathologies.   
 
 
Figure 4: Small molecule new chemical entities 1981-2008 by Newman et al. 2003 
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2.3 Pharmaceutical formulation in Garcinia kola and Garcinia spp.  
The development of effective and acceptable dosage forms for biologically 
active natural product delivery, both locally and systemically, has been investigated 
but it remains an important challenge due to the need to measure desirable biological 
activities, the diverse physical-chemical properties of individual molecules,  as well as 
the lack of standardization and performance in dosage forms and delivery systems.  
There are only a few cited research studies conducted proposing various formulations 
of Garcinia kola constituents such as a tablet, eye drops, and a toothpaste.  One of the 
formulation studies reported was a study in 2004 by Onunkwo et al. describing a 
compressed tablet formulation intended for use as an oral dosage form using a wet 
granulation method. Dosage form parameters were evaluated (tablet weight variation, 
thickness and diameter; hardness; content uniformity; friability; disintegration time 
and dissolution profile) in order to measure and qualify the physical properties of the 
Figure 5: FDA approved new molecular entities 1998:2012 (courtesy of FDA.gov) 
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tablets (Onunkwo et al., 2004).  Briefly, in their method, a chemical assay was 
conducted on the dry, powdered seeds as well as the crude aqueous extract of the 
seeds.  Next, the powdered material (50 mg) and an aliquot part of the crude extract 
(10 mg) were formulated into tablets using the wet granulation method. Extraction of 
the powdered seeds was performed using ethanol as a solvent and concentrated using a 
rotary evaporator, resulting in a dry mass.   After evaluating those parameters listed 
above, the results indicated that the tablets had acceptable disintegration time, 
dissolution, hardness and friability profiles. 
 A more recent study conducted in January 2010 at the Lagos University 
Teaching Hospital in Nigeria emphasized that untreated increases in pressure due to 
glaucoma in the eye can eventually lead to blindness. Accordingly, a new treatment 
based upon Garcinia kola was developed and tested for effectiveness in glaucoma 
patients. The study showed that a topical eye drop solution containing Garcinia kola 
(0.5% aqueous) extract significantly reduced eye pressure in patients with glaucoma 
using an intraocular dose twice a day.  The design of the study used commercial 
timolol 0.5% eye drops as a comparative control. Patient results showed that 47.8% ± 
0.8% of test subjects showed a significant reduction in eye pressure when using 
Garcinia kola as compared with a 48.2% ± 1.03% reduction in pressure in patients 
using the control.  It was concluded that Garcinia kola eye solution significantly 
reduced eye pressure and this effect was comparable to the effect of the commercial 
beta-blocking control, timolol (Adebukunola et al., 2010).  While these formulation 
studies underscore the utility and formulatability of certain crude Garcinia kola 
preparations, a formulation study of Garcinia kola comprising one of its purported 
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anti-viral benzophenones has yet to be reported.   
 A published research study on the isolation and identification of antiviral 
compounds was conducted by in 1999 by Fuller et al.  In short, a series of HIV-
inhibitory prenylated benzophenones known as guttiferones A-E was previously 
reported from extracts of three different genera (Garcinia, Clusia, and Symphonia) 
from the large plant family Guttiferae or Clusiaceae
 
(Gustafson et al., 1992).  Fuller et 
al. isolated the first member of the guttiferone F (also called garcinol) class of 
polyprenylated benzophenones from the genus Allanblackia (also in the Clusiaceae 
family).  In this study it is hypothesized that the same or similar antiviral compounds 
occur in, and may be isolated from, Garcinia kola since it is in the same genus.  If the 
Garcinia genus contains guttiferones A-E, there is a possibility that Garcinia kola 
might also contain guttiferone F; which has yet to be isolated and identified in 
Garcinia kola, which is said to have antiviral properties.   It is hypothesized that, by 
using the isolation methods of Fuller et al., the same or similar compounds may be 
isolated from Garcinia kola.  These are core to be answered by this research.   
One of the most important issues that arise when formulating natural products 
is poor aqueous solubility and stability.  Many new chemical entities display poor 
aqueous solubility.  However, there are many techniques used to possibly overcome 
solubility, such as nanosupensions, drug dispersion, and chemical modification.  
Nanosuspensions are colloidal dispersion of particles of a drug that are stabilized by 
surfactants.  Nanosupensions also increases dissolution rates due to a large surface 
area to unit volume ratio.  Drug dispersion in carriers which include solid solutions 
(solid solute molecularly dispersed in solid solvent), eutectic mixtures (fusion melt of 
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solute and solvent showing complete miscibility at or above all constituent melting 
points) and solid dispersion (dispersion of one or more compounds in an inert carrier 
in the solid state) (Gowthamarajan et al., 2010).  To be more specific, solid dispersion 
is used to improve the solubility of poorly soluble compounds, as well as mask the 
taste of a drug substance, improve the disintegration of oral tablets, and reduce the 
formulation particle size and thus increase the dissolution rate. This technique is 
widely applied in the pharmaceutical industry. The last technique that will be 
discussed for the use to overcome poor solubility is chemical modification.  Some 
examples of chemical modification are the formation of a salt complex and the use of 
a prodrug (Mohanachandran et al., 2010).
   
 As written in the previous paragraphs, solubility is a challenge in the 
successful formulation of compounds such as the benzophenones found in the 
Garcinia family.  An example of this is found in the work described by Bhaskar et al.  
According to Bhaskar et al., Garcinia mangosatana is proven to be active against 
Staphylococcus aureus, Staphylococcus epidermidis and Propionibacterium acne, 
which are responsible for the outbreak of acne.  Preformulation studies using a 
mixture of the aqueous extract of Garcinia mangosatana and with the excipient Aloe 
vera proved to overcome poor solubility and results shows Garcinia mangosatana to 
be a potential for drug delivery as a topical agent for the treatment of acne, which was 
the goal of the study. Another study of Garcinia mangostana (specifically α-
Mangostin) sought to improve the solubility and bioavailability of poorly-soluble α-
mangostin using solid dispersion (Aisha et al., 2011).  The poor solubility of α-
mangostin hinders its therapeutic application by limiting its oral absorption.  The study 
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showed an enhancement in the solubility of α-mangostin using solid dispersion 
systems.  Also, further research suggests the need for a new therapeutic strategy of 
HIV therapy due to the poor solubility of such compounds (Gupta et al., 2010).  
Overall, the formulation of Garcinia mangostana and HIV therapies in general are 
often shown to have issues of poor solubility and the utilization of a dispersion system 
maybe a useful technique for enhancing solubility.  Thus, it is hypothesized that if 
anti-viral Garcinia mangostana constituents derived from a plant from the same 
family as Garcinia kola, have poor solubility, than analogous materials derived from 
Garcinia kola could also display poor solubility and be amenable to solid dispersion 
or another solubility type enhancing formulation.  A carrier formulation that may 
protect the plant constituents from oxidation or hydrolysis, but that may also be useful 
for oral or topical delivery, such as a physiologically-compatible liposome, may be a 
viable formulation alternative. 
 In summary, there are antiviral compounds found in the Garcinia spp. There is 
a need on the market for more antiviral therapeutic drugs.  Research suggests that 
although there are many studies of Garcinia spp. which focus on formulation, the 
formulation of antiviral compound(s) from Garcinia kola is lacking. Now that we 
know what types of compounds are found within the Garcinia spp., it’s important to 
also look at different extraction techniques used to extract these compounds from their 
natural source.  
2.4 Extraction technique overview  
Extraction is a broad term used in the pharmaceutical industry and it involves 
the separation of medicinally active compound(s) of plants and or animals from the 
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inactive components by using solvents from extraction procedures. One of the most 
universal forms of extraction is brewing coffee: low molecular weight/concentration 
molecule (caffeine) is removed from the high molecular weight/concentration material 
(coffee bean). Another example is brewing tea which uses the same principle.  This is 
an example of solid/liquid extraction.  On the other hand, liquid-liquid extraction is 
commonly used in organic laboratory to separate and purify the desire product from a 
mixture leaving behind a starting material and by-products.  For example, the extracts 
from plants are fairly impure therefore standardized extraction procedures is needed 
for the final quality of the medicinal compound which can lead to a potential drug.  
Both techniques are governed by distribution coefficient, a measure of how an organic 
compound distribute between aqueous and organic phase. Distribution coefficient is 
very important in drug delivery because a drug must be carried throughout the body to 
its targeted site. A drug must have enough water solubility to dissolve in the blood and 
organic solubility to get through the cell.  Below are two extraction techniques used in 
the pharmaceutical industry as well as some advantages and disadvantages for their 
use.  
2.4.1 Liquid-Liquid extraction 
Liquid-liquid extraction/partitioning (the term solvent-solvent (S-S) extraction 
will be used interchangeable) is a method in which a desire compound is pulled from 
one solvent to another solvent only if the two solvents are immiscible (example oil and 
water, Figure 6).  The most common method of liquid-liquid extraction is using a 
separatory funnel. Separatory funnels are used to extract a compound either from or 
into an aqueous layer. Depending on the density of the solvent(s) repetitive use of the 
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separatory funnel or another type of extractor is needed.  Some advantage of using 
liquid-liquid extraction includes it being the simplest form of extraction every used for 
wide range of application in both chemical laboratories and pharmaceutical industries. 
Other advantages include the ability to operate in a continuous mode, and the use of 
two solvent phases.  One major disadvantage is the use and disposal of disposal of 
solvents used. In addition, this technique can be performed with simple equipment, 
and its selective separation is usually highly efficient.  
 
 
 
 
 
 
 
2.4.2 Supercritical Fluid Extraction (SFE) 
Supercritical Fluid Extraction (SFE) is a technique used to separate one 
component from another component using supercritical fluids as the extracting 
solvent. SFE is also an alternative sample preparation method generally used to reduce 
the use of organic solvents and increase sample throughput. SFEs are produced by 
heating a gas above its critical temperature or compressing a liquid above its critical 
pressure (Figure 7). Because of its low critical parameters (31.1
ᵒ
C, 73.8 bar), carbon 
dioxide (CO2) is the most used supercritical fluid used and is at times modified by co-
solvents such as methanol and ethanol in order to overcome polarity limitations. 
Figure 6: Separatory funnel (courtesy of Google image) 
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Advantage of using CO2 includes its favorable physical properties, its inexpensive, 
relatively safe and in abundance.  
 
 
 
 
 
 
 
 
 
 
A typical SFE system includes a CO2 source, a pump to pressurize the gas, an 
oven containing the extraction vessel, a pressure regulator, an analyte collector and a 
detector (Figure 8).  Another advantage of using SFE is its extraction procedure 
having little to no solvent residue and extraction at very low temperatures. The 
rationale for the use of SFE was because of its shorter extraction time, and selective 
extraction by varying temperature, pressure and or modifier.  
SFE has been used for various extraction and isolation of natural products 
including decaffeination of coffee, and extraction of hops, spices and tea because it is 
an eco-friendly alternative to chemicals and solvents used by chemist. This is because 
Chemist generate large amount of waste organic solvents which is growingly 
attributed in environmental pollution and hazardous to human health. However, the 
use of SFE in natural product extraction is limited to plant natural products.  
 
Figure 7: Phase diagram of Carbon dioxide, CO2 (courtesy of Google image) 
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The goal of the SFE technique was to search for garcinol by performing liquid-
liquid extractions, and SFE extractions with CO2, modifier which included methanol, 
ethanol, and isopropanol, and analyze via UPC
2
 coupled with Q-Tof-MS.  The second 
goal was to perform principal component analysis (PCA) of the SFE and S-S extracts 
in order to find correlations to streamline sample prep approach, exploit TransOmics 
workflows to aid visualization of data, targeted processing for garcinol, and 
comprehensive processing for feature differences.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8: Supercritical Fluid Extraction system (courtesy of Waters Corporation)  
Oven  
Collector 
Detector 
Extraction 
vessel 
Pressure 
Regulator 
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CHAPTER 3 
 
METHODOLOGY 
Both separation techniques, Solvent-solvent (S-S) and Supercritical Fluid 
Extraction (SFE) were conducted and analysis was performed by Reversed-Phase 
High Performance Liquid Chromatography (RP-HPLC) using Ultraviolet Photodiode 
Array (UV-PDA) detection, Proton and Phosphate Nuclear Magnetic Resonance 
(
1H
NMR and 
31P
NMR), and Ultra Performance Convergence Chromatography (UPC
2
) 
coupled to Quadrupole Time of Flight Mass Spectroscopy (Q-ToF/MS).  Biological 
assay was conducted and compared to controls. Characterization of the liposome 
formulation was performed using Differential Scanning Calorimeter (DSC) and 
Dynamic Light Scattering (DLS).  Lastly, the rate of release and extent of release was 
conducted using dissolution tests. The follow discuss the materials and methodology 
used. 
3.1 Materials 
Garcinia kola nuts (2 kg) were purchased from Gold Coast Trading Company 
(Bronx, New York) in January 2011.  Organic solvents (hexane, methanol, acetone, 
dichloromethane, and methyl-tert-butyl ether (MTB) were purchased from Fisher 
Scientific (Fair Lawn, New Jersey).  Sephadex LH-20 resin for size exclusion 
chromatography was purchased from Sigma Aldrich (St. Louis, MO).  Potassium 
phosphate monobasic and dibasic was also purchased from Sigma-Aldrich (St. Louis, 
MO).  The active antiviral compound Garcinol (MW 602.8) was purchased from Enzo 
Life Sciences (Farmingdale, New York). For the liposome formulation study, 1, 2-
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Dipalmitoyl-sn-glycero-3-phosphocholine monohydrate (DPPC) was purchased from 
Corden Pharma Switzerland LLC (Switzerland).  Cellulose membranes (Spectra/Pro ® 
Float-A-Lyzer® G2) with a molecular weight cutoff of 3500D used for drug release 
tests were purchased from Spectrum Laboratories Inc. (Rancho Dominguez, 
California).  
3.2 Extraction techniques 
The following sections include the extraction methodology employed on Garcinia 
kola using the two extraction techniques mentioned above. 
3.2.1 Liquid-liquid extraction  
 
Two kilograms of Garcinia kola nuts were spread on a plastic bag and dried in 
a Robertshaw Drying Oven at 135
ᵒ
F for five days. Upon exhaustive drying, the nuts 
were peeled and the peelings were kept separately for future evaluation.  The nuts 
were ground using a coffee grinder yielding a total of 1071 grams of ground material.  
One kilogram of the ground nuts was weighed and transferred to a large glass 
chromatography extraction column with a mechanical mixer.  Three liters of hexane, 
then three liters acetone, then three liters of methanol, and then with one liter of a 
combined 1:1 methylene chloride-methanol was then introduced to the nuts 
respectfully.  It is important to note that one liter of solvent was added at a time, mixed 
for 12 hours to 24 hours, and then removed.  This entire process was monitored for 
roughly six days. The seeds were also subject to other solvents including ethyl acetate 
and chloroform (<250 mL each) solvent extraction scale.  The various solvent systems 
served as a removal vehicle of compounds found in Garcinia kola nuts.  After each 
successive extraction, the solvents were removed by rotary evaporation, and the 
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resulting residues were labeled, sealed, covered and stored.  The hexane extract was 
bright yellow, and the acetone and methanol extracts reddish-brown and brownish-red, 
respectively.  
Next, the method described by Fuller et al., comprising solvent-solvent 
extraction (hence the use of the term S-S because the rotary evaporated samples, 
mentioned above were re-introduced to solvent),  was applied to the initial extract 
residues by combining a 5 g portion of the 1:1 methylene chloride-methanol and 
methanol extracts (2.5g each).  This combination was further separated by solvent-
solvent partitioning into hexane (200 mL), methyl-tert-butyl ether (MTB, 10 mL), 
ethyl acetate, and water.  The purpose of partitioning was to ensure that the 
compounds were separated based on their solubilities into two different immiscible 
liquids.  In short, after the portioning fraction was added to the separating funnel with 
the 1:1 methylene chloride-methanol and methanol extracts combined, the funnel was 
closed, shaken abruptly which lead to one phase (hexane for instance) being separated 
out from the 1:1 methylene chloride-methanol and methanol extracts phase and slowly 
opening the tap of the funnel and collecting each immiscible fractions.  The 
partitioned hexane, MTB, ethyl acetate and water fractions were labeled, sealed with 
aluminum foil and Parafilm® around the neck of the beaker, and placed in the 
laboratory refrigerator in Fogarty 41. 
The MTB fraction was passed through Sephadex LH-20 loaded into a glass 
chromatography column using 1:1 methylene chloride-methanol as the mobile phase, 
yielding 8 fractions. The third and fourth fractions were collected are noted as 
(Sephadex fraction 3/4).  An illustration of this protocol is further depicted in Figure 9, 
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all of which were analyzed by analytical techniques in section 3.3.  
 
 
 
 
  
 
 
 
 
 
 
 
 
3.2.2 Supercritical fluid extraction (SFE)  
 
Sample preparation for the SFE experiment was performed by weighing out 1 
gram of Garcinia kola nuts which were placed in empty white tea bags, the bags were 
folded and stapled shut. The tea bags were placed in a metal vessel and sealed tightly.  
The vessels were then loaded into the oven portion of the SFE. Valves were 
connected, the instrument set with 100% carbon dioxide (CO2), and organic solvent 
modifiers, including methanol (MeOH), ethanol (EtOH) and isopropyl alcohol (IPA) 
5%, 10% and 30% each by w/w. Each sample collected was subjected to various 
analytical methods also mentioned in section 3.3.  
3.3 Analytical analysis 
The following sections include the analytical analysis of samples extracted and 
collected with both extraction techniques mentioned previously. 
3.3.1 Reverse Phase High Performance Liquid Chromatography (RP-HPLC) 
Figure 9: Flow chart of Guttiferone F isolation (Fuller et al 1999) 
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High Performance Liquid Chromatography (HPLC) is an analytical technique 
used to separate, identify and quantity components in a mixture.  HPLC has been used 
in various industries including medical, legal and manufacturing.  With a slightly 
higher operating pressure (50 bar-350 bar), it contains a mobile phase which is 
typically an organic solvent, and a hydrophobic stationary phase (hence, reverse 
phase) which is typically a solid absorbent material, 2-50µm in size.  There are two 
types of phases in chromatography: normal phase and reverse phase. The term 
“reverse phase” refers to any chromatography methods that uses hydrophobic 
stationary phase.  HPLC separation is due to the different degrees of interaction with 
the solid adsorbent material which is why it’s so widely used.  Components of a 
typically HPLC system includes: a liquid analyte (sample), pumps used to push the 
analyte through the column, an injector, a non-destructive detector, such as phased 
diode array or ultraviolet where the analytes can be recovered and a computer 
analyzing system.   
In brief, the analytes are prepared, injected, carried to the column by a pump 
where it’s separated and lastly detected then recorded yielding a spectra which shows 
the analyte’s characteristic fingerprint. The HPLC method used was an isocratic 
acetonitrile-water (0.1% Glacial acetic acid) detection range from 190 to 400 nm 
(baseline check at 220 nm, 230 nm, 256 nm, and 282 nm).  The column used was an 
Agilent Zorbax SB-C8, 250mmx4.6mm, 5µ, at a flow rate of 1 milliliter per minute 
and the run time was 20 minutes.  Detection wavelengths were set to collect within a 
range between 200 nm to 400 nm.  The Garcinia kola extracts were subject to this 
isocratic method on each of the separation process found in Figure 9.  
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3.3.2 Ultra Performance Convergence Chromatography (UPC
2
) coupled to 
quadrupole time-of-flight Mass Spectroscopy (Q-Tof-MS) 
Mass spectrometry (MS) is an analytical technique used to measure molecular 
weights, observe elements present in a compound and provide more information about 
its molecular structure.  To do so, the element must be ionized (remove one or more 
electrons creating a charged particle) by a magnetic field.  Because of the magnetic 
field, the ions in the element are accelerated so that they all have the same kinetic 
energy and are measured according to their masses. There are various ways the 
elements can be ionized electrospray ionizer (ESI) being the most popular. ESI works 
by applying high voltage to a particle producing an aerosol of ions. ESI is great for 
producing ions from macromolecules because it takes into account fragmentation of 
ions.  ESI is also used for producing multiple charged ions and widening the mass 
range of bigger compounds like proteins and polypeptides. Most mass spectrometer 
works in negative ion, ESI(-), and positive ion, ESI(+), electrospray ionization mode 
depending on whether the observed ions are negatively or positively charged. 
After the ionization step, the data system then reads the digital information 
(mass to charge ratio, m/z) displaying it as a mass spectrum. There are also different 
ways that the mass to charge ratio can be analyzed: Quadrupole mass analyzer and 
Time of Flight (ToF) mass analyzer being two popular examples.  As the name 
implies, quadrupole has four cylindrical rods which are set in parallel.  The purpose 
for the quadrupole is to filter the mass based of the mass to charge ratio as electric 
field is being applied to the rods. Time of Flight on the other hand, determines the 
mass to charge ratio based on a time measurement, the time it takes the particle to get 
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to the detector at a known distance.  The time depends on the mass to charge ratio: 
heavier particles takes longer and vice versa. When both the quadrupole and time-of-
flight mass analyzer instruments are combined and used this way, a more accurate 
mass measurements and fragmentation experiments can be carried out. 
Another type of chromatography used is Ultra Performance Convergence 
Chromatography (UPC
2
).  UPC
2
 is also an analytical technique that incorporates the 
re-design of a chromatographic system using liquid carbon dioxide (CO2) as the 
primary mobile phase. UPC
2 
uses both gas and liquid as mobile phases; hence, the 
term convergence.  A co-solvent or modifier, typically methanol, is used as an elution 
solvent. The technique follows the principles and selectivity of normal phase 
chromatography (hydrophilic stationary phase).  UPC
2
 also uses stationary phases 
consisting of smaller particle size (< 2 µm) therefore providing greater efficiencies 
that results in a greater resolving power capable of separating more analytes per unit 
time. UPC
2
 works great for improving the productivity, efficiency, and throughput of 
samples.  It reduces retention times, and thus processing cost, and drastically reduces 
solvent usage.  Alternating high and low collision energy was performed during a 
single injection, a technique known as MS
E
, which uses two different steps of mass 
spectroscopy, allowing for precursor and product ion determination. This method is 
used for finding out related substances of the compound of interest.  The alternating 
scanning provides accurate mass measurement for all detectable ions for the system 
and provides faster speed and resolution. By applying a collision energy field, MS
E 
can be applied in an aim to measures the molecule’s distinct fragmentation pattern 
which provides structural information.  Note that Base Peak Intensity (BPI) was used 
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as a trace that subtracts the background noise in the spectra.  UPC
2
 may also be 
coupled to quadrupole and time-of-flight mass analyzers (Q-Tof MS) in order to target 
a broad range of compounds in complex samples.  And this technology is used in 
order to comprehensively acquire data, locate and identify known compounds, identify 
unknown peaks of interest, and elucidate structures of unknown.  
 
 
 
 
 The workflow employed for the chemical profiling of Garcinia kola is 
described in Figure 10.  Extracts from the samples listed in Figure 9, were analyzed 
using Waters ACQUITY UPC
2
 instrumentation.  An ACQUITY UPC
2
 BEH column 
with dimensions 3.0 x 100mm; 1.7um was observed as providing the best separation 
with the greatest number of peaks. Ethylene Bridged Hybrid (BEH) columns are used 
in small molecule to large biopharmaceutical analysis. MS data acquisition was 
performed using Waters Xevo G2 Q-ToF.  Alternating high and low collision 
energies, 5V and 30V, respectfully, allowed for precursor and product ion 
determination as stated above.   
3.3.3 Nuclear Magnetic Resonance (
H
NMR and 
31
P-NMR) 
Nuclear Magnetic Resonance (NMR) is a spectroscopic technique used to 
study nuclei with non-zero nuclear spins.  All nuclei contain protons hence they have 
charge and spin.  Many nuclear spin values are possible.  The most important are those 
with spin ½ such as 
1
H and 
31
P that are relevant here.  When these non-zero nuclear 
Figure 10: Workflow overview analysis (courtesy of Waters Corporation) 
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spin nuclei are placed in a magnetic field, two spin states form; one of higher energy 
and a more abundant lower energy state.  NMR is detected by observing the spins 
moving between these energy states after an electromagnetic pulse.  NMR can be used 
to investigate molecular structure using proton 
1H
NMR as well as investigate lipid 
bilayer structure packing with phosphorus 
31
P NMR. 
The result of an NMR experiments is reported as a chemical shift (δ, delta) 
from a reference compound and is measured in parts per million (ppm). The 
1
H 
chemical shift range is approximately 0 to 10 ppm (on a scale from right to left). The 
31
P chemical shift range is approximately 250 to -250 ppm.  
1
H nuclei resonate at 
different chemical shifts as a function of the electron density around them which is 
dependent on the molecular structure.  As the electron density surrounding the nucleus 
increases, the chemical shift decreases. 
1H
NMR is used to study bond connectivity which leads to identification and 
information about the molecular structure.  Protons in different chemical environment 
have characteristic chemical shifts and these known chemical shifts can be used to 
determine molecular structures.  In addition to the chemical shift data, protons near each 
other display the fine structure because they sense the presence of the neighboring protons 
through bonding electron pathways for protons less than three bonds away.  These close 
connections can be determined with a Correlated Spectroscopy (COSY) experiment. COSY 
data allows groups of coupled protons to be identified and then these groups are used 
to build up network of protons to determine the molecular structure.  
1H
NMR spectra observed the stability of the protons found in the garcinol 
molecule were acquired on a 300 MHz 1H NMR spectrometer. Testing was performed 
on garcinol and the hexane extract. The sample preparation comprised of dissolving 36 
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mg of garcinol and 36 mg of the hexane extract residue in 1 mL of deuterated 
methanol and each placed in a 5-millimeter NMR tube. The samples were then placed 
in the NMR system and results were generated and displayed as an intensity plot.  
Phosphorus NMR can be used to assay purity and to assign structures of 
phosphorus containing compounds. In biological applications, this approach is used to 
study the lipid bilayer and membranes in various conditions. It can provide 
information about lipid bilayer packing, phase transitions, and lipid head orientation.   
31
P-NMR spectra of DPPC liposomes were acquired on an Agilent NMRS 500 
NMR spectrometer using 5mm NMRone probe operating at 202.3 MHz.  The probe 
temperature was set at 37 °C for all experiments.  Liposome formulations analyzed by 
NMR were prepared as described in section 3.5 with the exception that 10% 
deuterated oxide (heavy water, D2O) in water was used as a solvent in order to provide 
a deuterium lock signal.  NMR data were collected for 60,000 scans with a 35.7 kHz 
sweep width using 131 K data points. Acquisition time was 1.3 sec with a relaxation 
delay of 0.5 sec. The data were processed with Mnova program V8.1 Mesterlab 
research SL. A line broadening of 50 Hz was applied to all spectra.  All spectra were 
indirectly referenced to phosphoric acid (H3PO4) set to 0 ppm.  Data were acquired 
without spinning. 
3.4 Biological Assay 
Antiviral and cytotoxicity evaluation of three selected extracts of Garcinia 
kola (Table 1 and Figure 9) were conducted in the laboratory of Rega Institute for 
Medical Research at the University of Leuven in Belgium.  The tetrazolium-based 
colorimetric (MTT) assay using MT-4 cells (C8166 cells) were used for the detection 
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of anti-HIV compounds. The MTT assay measures cell viability (mitochondrial 
activity), if cells are viable, tetrazolium dye is reduced and undergoes a color change, 
which can be detected and quantified.  These tests were performed against HIV-1 
(strain IIIB) and HIV-2 (strain ROD) on MT-4 cells which are Human T cells isolated 
from a patient with adult T-cell leukemia which supports HIV growth.  HIV-1 (strain 
IIIB) was provided by the National Institute of Health and HIV-2 (strain ROD) was 
provided by Pasteur Institute, Paris France. The process for the replication of the HIV 
virus occurs within 5 days.  In short, infected cells were cultured, treated, incubated, 
and evaluated to determine the IC50s and CC50s of the extracted compounds.  These 
tests were carried out in quadruplicate. The 50% inhibitory concentration (IC50) was 
defined as the inhibitor concentration that reduced the level of the HIV viral 
expression by 50%. The 50% cytotoxic concentration (CC50) was defined as the 
concentration of compound that inhibited MT-4 cell proliferation by 50%. Cell 
viability was taken into account relative to controls which were: nevirapine, 
lamivudine, azidothymidine, and dideoxyinosine, all of which are reverse transcriptase 
inhibitors (RTi) drugs effective against HIV and are available commercially.   
Code Sample 
WOR/001A 1:1 (DMC-MeOH)-Hexane partitioned in 
Hexane 
WOR/003/4 1:1 (DMC-MeOH)-MeOH combined 
WOR/003/4
b 
MTB extract 
 
3.5 Preparation of liposome formulations  
Liposomes are hollow bi-lamellar or multi-lamellar spheres (vesicles) typically 
comprised of physiologically compatible lipids.  These membrane-like structures have 
Table 1: Antiviral assay samples 
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two different phases: at low temperature (before transition temperature) rigidity occurs 
as a gel-like phase and at higher temperatures (above transition temperature) a liquid 
crystal phase is formed. These phases are dependent upon how the lipids in the 
bilayers of the liposomes are arranged.    
Liposome preparation was performed using the film rehydration method using 
garcinol as an active pharmaceutical ingredient (API).  The garcinol liposomes 
vesicles were prepared by dissolving 43.75 mg of DPPC in 3.5 ml of methanol (2 mM 
lipid concentration).  Methanol was removed by rotary evaporation at 50
 ᵒ
C starting at 
450 mbar for 30 minutes, then at 300 mbar for 30 minutes and lastly at 200 mbar for 
30 minutes.  As a side note, the lipids were first rehydrated in 137 mM PBS (pH 7.4) 
in which garcinol degraded.  From this observation, several biological buffers were 
tested in the presence of garcinol in order to determine garcinol stability in the optimal 
buffer solution. Results of this stability test are shown in section 4.5.5.  Potassium 
phosphate buffer (PPB) at pH 7.4 was selected as the most stable buffer.  The lipid 
film was then rehydrated with 2 mM garcinol in 50 mM PPB for 30 minutes at 50 ᵒC 
above the DPPC transition temperature. Dynamic light scattering (DLS) was 
performed after sonication of the hydrated lipid film to confirm the particle size and its 
distribution.  Finally, the liposome formulation was subject to release studies in order 
to assess the rate and extent of garcinol release. 
3.5.1 Sonication 
After the liposomes were make, its particle size was very large. To improve 
and decrease the size of the liposomes, they were carefully sonicated for 2 minutes at 
50% amplitude. 
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3.5.2 nano-Differential Scanning Calorimetry (nano-DSC)  
Differential Scanning Calorimetry (DSC) is used to measure melting 
temperature, heat of fusion, latent heat of melting, reaction energy and temperature, 
glass transition temperature, and precipitation energy and temperature, denaturation 
temperatures, and specific heat or heat capacity.  DSC measures the amount of energy 
absorbed or released by a sample when it is heated or cooled, providing quantitative 
and qualitative data on endothermic and exothermic processes.  DSC also measures 
the degree of crystallinity as well as the drug release profile which can be used to 
optimize formulation of suspensions/emulsions and predict long term stability.  This is 
done by the change in the heat that flows through the sample and a reference at a 
certain temperature is observed as the test temperature changes.  An empty aluminum 
pan serves as the reference sample. Data is measured as a function of temperature, 
which is typically varied over a period of several minutes 
The liposome 1, 2-Dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) in Figure 
11 which is a neutral phospholipid containing two palmitic acid (16-carbon saturated 
chains) esterified to glycerol with a phosphate group and choline attached at the polar 
end was used. The phase transition temperature of DPPC from gel to liquid crystal is 
42 °C, higher than human body. DPPC is surface active and fervently forms 
liposomes, with the molecule actively comprising a high compaction capacity as a 
result of the free rotation and attraction of the palmitoyl tails to each other.  
 
 
 Figure 11: 1, 2-Dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) (courtesy of Google image) 
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Analysis of the DPPC liposome was performed using a DSC Q100 from TA 
Universal Instruments.  Here, 300µL of the sample was weighed and placed in an 
aluminum pan with a cover.  The heating rate was 10 °C/min from 0 
ᵒ
C to 180 °C 
under 40 cm
3
/min nitrogen flow.  The DSC apparatus was set equilibrated at 20 °C.  
Run time was roughly 2 hours. Upon the conclusion of the sample run, 1 L of 
deionized water was used to clean the DSC apparatus to ensure that there were no 
liposomes left stuck in the apparatus.  Data was further assessed on the instruments 
software.  
The same theory discussed in the previous paragraph is applicable to nano-DSC 
but on a nano scale (nanometers, nm, in size). Nano-DSC was performed using a TA 
Instruments Nano DSC (New Castle, DE, USA). Samples at a concentration of 0.1 
mM lipid were degassed under vacuum for 30 min before loading into a 0.6 mL 
capillary cell. The cell was then pressurized with nitrogen to 1 atm and equilibrated at 
25 °C. The sample was scanned at 1 °C min
-1
 over a range of 25 °C to 60 °C.  
3.5.3 Zeta potential 
The fundamental states of matter are solids, liquids and gases. A colloidal system 
occurs when one of the states of matter is finely dispersed in another. This effect is 
evident in measuring thermal analysis by observing a particles’ zeta potential.  Zeta 
potential, Greek letter (ζ), ζ-potential, measures a fluid containing particle (in this case 
the dispersion of the garcinol liposome) in a colloidal system. It measure the electrical 
potential difference between the double layer of a particle at the slipping plane with 
respect to the bulk liquid away from the interface as seen in Figure 12.  This 
measurement provides detailed information about the stability of the colloidal system. 
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Particles within the dispersion with a zeta potential tends to move toward the electrode 
of opposite charge with a velocity relative to the amount of zeta potential. This 
velocity is observed when the particle mobility is captured by the laser which is then 
converted to zeta potential. A smaller molecule that has a high zeta potential (let’s say 
±60 mV) means that the molecules in solution resist aggregation (electrically stable) 
hence exposing charged phosphate groups. However, coagulation occurs at lower zeta 
potential (±5 mV).   
 
 
 
 
 
 
 
 
 
 
There is no direct way to measure zeta potentials but there have been various 
theoretical models and experimental techniques used to calculate it. A known 
theoretical model used to describe the stability of a colloidal system is the DVLO 
theory; named after its discoverers Derjaguin, Landau, Verwey and Overbeek. DVLO 
theory states that the stability of a particle in solution depends on its total potential 
energy (VT = VS + VA + VR) which consists of the total energy (VT) produced by the 
Figure 12: Zeta potential definition (courtesy of Google image) 
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solvent (VS), total attractive forces (VA) and the total repulsive force (VR). In order to 
obtain stability in colloidal systems, there should be minimal attractive force and 
repulsion in order to resist the flocculation of particles.  One experimental technique 
used to estimate zeta potential of a particle in other words measure colloidal stability 
is electrophoresis. 
A small aliquot part of each formulation (17 mM DPPC) was diluted with 137 
mM PBS to give a final lipid concentration of 1 mM.  Zeta potential values were then 
determined using a laser doppler procedure with a Malvern Instruments Zetasizer 
Nano ZS at 25 °C. Air drop interference was eliminated before measuring the zeta 
potential. 
3.5.4 Differential Light Scattering (DLS)  
Differential Light Scattering (DLS) determines the size distribution profiles of 
particles in suspension. This occurs by a light (often a laser) hitting a particle (in this 
case the garcinol liposome), producing an electronic distortion that is emitted in all 
directions.  An oscillating dipole in the electron cloud results. As the dipole changes, 
energy is scattered in all directions and a fluctuating (or dynamic) intensity which 
captures the size of the particle in solution is obtained. Smaller particles undergo 
Brownian Motion, random motion of particles in a liquid or gas resulting from 
collision molecules in the gas or liquid. And the distance between scattering changes 
consistently with time.   
DLS was carried out after sonication of the hydrated lipid film to confirm the 
liposome particle size and its distribution. DLS measurements were performed using a 
Malvern Instruments Zetasizer Nano ZS with a backscattering detector angle of 173° 
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and a 4 mW, 633 nm He-Ne laser (Worcestershire, UK).  For size distribution studies, 
1 ml of the liposome formulations was analyzed in an optical grade polystyrene 
cuvette at 37 °C.  Before analysis, the samples were stored at 37 °C and then evaluated 
after 24 hours. 
3.5.5 Dialysis 
During the film rehydration stage of liposome (vesicle) preparation, a certain 
amount of PPB that was not trapped in the vesicles had dissolved garcinol in it. 
Consider also that all of the garcinol might not have been entrapped and some may 
still be present in the untrapped PPB. To overcome these potential barriers, the 
garcinol liposomes were subjected to dialysis studies in order to remove any untrapped 
drugs so that only the release of drugs from the vesicles could be accounted for. The 
dialysis experiment was carried out until a constant drug concentration was obtained 
and that equilibrium had been achieved in order to ensure no unentrapped garcinol was 
present in the sample. 
Dialysis experiments were conducted at room temperature (25 ± 0.5 °C) using 
MWCO 3500 kD cellulose membranes for 24 hrs in 50 mM potassium phosphate 
buffer solution with constant stirring so that any potential unencapsulated garcinol was 
removed.   
3.5.6 Dissolution 
        Extensively used in the pharmaceutical industry, dissolution studies provide 
information about drug release for various dosage forms.  Dissolution studies were 
conducted in order to determine the garcinol release profile from the liposome 
formulation.  Dissolution studies are importanin in predicting the bioavailability of 
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various drug formulations. Dissolution was performed by transferring the dialysis tube 
into a smaller beaker of 50 mM potassium phosphate buffer (37 ± 0.5 °C) solution at 
pH of 7.4 with a magnetic stirrer at 75 rpm. As 1 ml buffer samples were collected for 
analysis of 24 hrs period, the buffer was replaced with new buffer in order to maintain 
a sink condition.  Dissolution samples were collected at serial time points and were 
analyzed for garcinol content by HPLC in order to quantify release over time.   
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CHAPTER 4 
 
RESULTS AND DISCUSSION 
4.1 Liquid-liquid extraction technique results 
After the extraction and fractionation of Garcinia kola as described in the 
previous chapter, the samples that, based upon Fuller et al., would most likely contain 
guttiferone F. were analyzed using HPLC using an acetonitrile-water mobile phase. 
The samples are: methanol extract, MTB extract, Sephadex fraction 3/4 and three 
other samples were also analyzed by HPLC: the hexane extract; the ethyl acetate 
extract; and chloroform extract. These samples were noted as solvent-solvent (S-S). 
The results obtained from the HPLC analyses are represented in the HPLC 
chromatogram displayed in Figure 13. 
 
Results in Figure 13 shows the S-S samples were overlaid and compared to 
Figure 13: HPLC chromatogram overlaid of each solvent-solvent extraction sample (methanol, MTB, 
Sephadex 3/4, hexane, ethyl acetate, chloroform extracts) and the injection of the Garcinol standard using the 
80:20 (w/w) acetonitrile-water mobile phase. 
← Guttiferone F ↑ 
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that of the garcinol standard peak.  The results indicate that of the majority of the 
analytes in the S-S extracted samples had a retention time before 9 minutes. The 
results also indicate that none of the other extracts contained detectable analytes with 
the same retention time as that of garcinol, which has a retention time roughly 12.5 
minutes. This suggests that the antiviral compound of interest, garcinol was either not 
present in any of the S-S extracts or was present at a concentration below the limits of 
detection of the HPLC assay.  
4.2 Supercritical fluid extraction (SFE) results  
The goal of the SFE technique was to search for guttiferone F. via 100% CO2, 5%, 
10%, 30% modifier extractions which included methanol, ethanol, and isopropanol, 
and analyze via UPC
2
 coupled with Q-Tof-MS.  The second goal was to perform 
principle component analysis (PCA) of the SFE and S-S extracts in order to find 
correlations to streamline sample prep approach, exploit TransOmics workflows to aid 
visualization of data, targeted processing for garcinol, and comprehensive processing 
for feature differences found in the next section. 
Results shown in Figure 14 are of the HPLC overlaid chromatograms for each 
of the SFE extractions and are compared to an injection of garcinol standard.  
Synonymous to the previous section, results indicate none of the extracts contained 
detectable analytes with the same retention time as that of garcinol, which has a 
retention time of roughly 12.5 minutes.  This also suggest that the antiviral compound 
of interest, garcinol was either not present in any of the SFE extracts or was present at 
a concentration below the limits of detection of the HPLC assay. 
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4.3 Comparison of both extraction techniques  
After compiling the HPLC overlay as in Figure 13 and Figure 14, it was 
determined that the compound Garcinol was not detected in any of the extracts.   In an 
effort to maximize our understanding of the various extraction methods employed, 
comparisons were performed such to determine the amount of coverage for each 
extraction technique by their mass.  Questions regarding types of analytes and 
variations between the extractions became objectives in determining an appropriate 
guidance for future studies and protocols for researchers performing natural product 
profiling.  Data was obtained on the UPC
2
 coupled to Q-Tof MS by negative 
electrospray mode. Plots were constructed in order to observe trends related to 
components in the S-S extracts and the SFE extracts.  Statistical analysis techniques 
were used to determine differentiation between techniques by utilizing principle 
component analysis (PCA).  PCA measures statistical analysis of variability in the data 
Figure 14: HPLC overlaid chromatograms of the SFE extractions and the injection of the Garcinol 
standard.  
 ←  Guttiferone F ↑ 
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set in order to make understanding and find a correlation. PCA and quadrant 
assignment afford an opportunity to understand and appreciate the composition 
similarities between fractions and extractions techniques. The results, shown in Figure 
15 are split up into four quadrants denoted as 1, 2, 3 and 4.  Each quadrant indicates if 
the sample components are similar and associated near each other, or their extracted 
masses were found to be within close proximity of each other and or overlap. An 
analysis of the samples in both S-S and SFE techniques is summarized in Figure 15.  
The components derived from the Sephadex fraction 3/4, MTB, and chloroform are 
associated with quadrant 2, while the most of the SFE as well as hexane and ethyl 
acetate components are nearly overlapping in quadrant 3 of the trend plot.  Implying 
that similar mass were extracted being that they are in proximity to each other.  The 
one extraction profile that was observed significantly different the rest of the 
extraction groups was the 5% EtOH results, which is the outlier located on the bottom 
right.  
 
 
 
 
 
 
 
 
 
Figure 15: Trend plot of solvent-solvent and SFE samples as determined by principle component analysis (PCA)  
1 2 
3 4 
Outliers 
Outliers 
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In order to look more in detail at the SFE fraction, quantitative analysis was 
performed using mass spectroscopy. Figure 16 displays the results are of the TOIML 
dendrogram and abundance plot which shows an example of how a single feature of 
the quantitative data which was examined and aided justification for consideration to 
statistically group the S-S and or SFE.  The top of the plot shows the different samples 
of both extraction techniques. As observed, there are three different replicates within 
the SFE 5% EtOH (left, indicated by □) and the Sephadex 3/4 (right, also indicated by 
□).  Implying that for this single spectrum feature at retention time 1.05 minutes and 
m/z=499.2848, was grouped as being found in both the SFE (5% EtOH) and S-S 
(Sephadex fraction 3/4) techniques 
 
(see Graph 1, 2 and 3).  This grouping is termed chemical features. A total of 1291 
individual chemical features were observed in the entire S-S and SFE samples (Figure 
17, in percent), analyzed and placed into the following three categories: SFE, S-S and 
neglect. Neglect represents neither of the S-S and or the SFE samples were observed 
with a mass standardized normalized abundance (items under consideration) of zero 
Figure 16: TOIML dendrogram data and abundance plot of a single feature (RT 1.05min; m/z=499.2848) found in 
both 5% EtOH (left) and Sephadex fraction 2 (right) extractions.  
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and or below zero.   
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Graph 1: Breakdown of the total features found in solvent-solvent (S-S) and Supercritical fluid extraction 
(SFE) determined by a normalized abundance .1% based on the TOIML dendrogram data set 
Graph 2: Percentage breakdown of the total features found in S-S extracts as observed. 
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Graph 4: Garcinol (bottom) in comparison to other solvent-solvent extracts (chloroform, Sephadex 3/4, hexane, 
MTB, and ethyl acetate, respectfully. Results indicate no presence of garcinol in any S-S fractions.  
Graph 3: Percentage breakdown of the total features found in SFE extracts as observed. 
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The results of the 1291 features in Graph 1, 20.67% are neglected. Of the remaining 
detectable compounds indicated, 50.74% of the extracted compounds can be extracted 
Graph 5: UPC2/MSE ES– BPI MS traces of the IPA (30%, 10%, and 5%) SFE and 100% CO2 extractions from 
the top to the bottom.  Garcinol was not observed to be present in these or any of the other SFE extractions 
with MeOH and EtOH 
  
 
Graph 6: UPC2/MSE ES– BPI MS traces of the Methanol (30%, 10%, and 5%) SFE and 100% CO2 extractions 
from the top to the bottom.  Garcinol was not observed to be present in these or any of the other SFE 
extractions with IPA and EtOH 
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by SFE technique and 55.46% can be extracted by S-S technique indicating both 
extraction techniques nearly extract the same amount of compounds/masses. Of the 
55.46% extracted by S-S, majority was extracted using the Sephadex fraction, as 
shown in Graph 2.   Likewise, of the 50.74% extracted by SFE, the majority was 
extracted by the use of 5% EtOH modifier, as shown in Graph 3. In addition, 26.6% of 
the abundant features are extracted by both extraction techniques (not shown).  Results 
for garcinol standard indicate a broad UPC
2
 chromatography peak eluting at 4.0 
minutes. Mass accuracy of the garcinol standard by ESI(-) was measured to be 1.3 
ppm.  Results of the S-S and SFE techniques indicated no presence of garcinol in any 
extract when based on ESI(-) located in Graph 4-6. The SFE fraction of EtOH was not 
shown for simplicity purposes; it too, indicated no presence of Garcinol based on 
ESI(-). Garcinol was not found in Garcinia kola when following the extraction 
procedure described in the Fuller et al. publication. However, common ESI(-) m/z 
components found in all extracts in Graph 4 to 6 were m/z=425.26 and m/z=365.17. 
The observation of these common components could further provide a more insight 
into the extracts within Garcinia kola.  
Next we examined garcinol at high and low collision energy as well as 
molecular fragmentation of garcinol. Figure 17 and Figure 18 represents that data. 
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Figure 18: MSE precursor and product ion data: major fragment used to confirm the presence of Garcinol. 
Low Collision Energy: 5 V 
High Collision Energy: 30 V 
Figure 17: Garcinol MSE data at high and low collision energy with BPI trace. 
Garcinol 
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The purposes of these experiments were to detriment the parent ion 
information at low CE and then get fragmentation data from the high CE.  From the 
fragmentation data, we can use the spectra to look for common fragment ions in the 
spectra of other detected peaks. The four major fragments of garcinol are: m/z109, m/z 
409, m/z 465, and m/z 273. Although not shown, UPC
2
/MS
E
 ES-BPI MS trace of 
garcinol standard confirms a mass accuracy for the elemental composition of Garcinol 
(C38H49O6).  Retention time observed to be 4 minutes (Figure 17).  The four major 
fragment ions (Figure 18) were used to confirm if garcinol presence were found in the 
extracted samples all of which came back negative. 
4.4 Biological Study  
The results for the cell-based, MTT anti-viral assay are listed in Table 2. The 
three Garcinia kola extracted samples tested were completely inactive against both 
HIV-1 (strain IIIB) and HIV-2 (strain ROD).  The extracted samples have a high 
cytotoxicity CC50 values >60 µg/ml as compared to the control lower CC50 values >20 
µg/ml.  These data are consistent with the HPLC and MS data which also suggest that 
garcinol is not present in any of the extracted compounds (S-S and or SFE); if indeed 
garcinol is an active in vitro antiviral agent.  
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4.5 Garcinol formulaiton study 
The following are the results represent the antiviral formulation studying where 
Garcinol acts as the active pharmaceutical ingredient.   
4.5.1 Zeta potential  
The surface charge was measured through Zeta potential measurements and the results 
predicting the stability of the colloidal system below in Graph 7. 
 
Code Strain Exp_nr IC50(µg/ml) CC50(µg/ml) SI Max Prot(%) Appr. av.IC50(µg/ml) SD av.CC50(µg/ml) SD SI
WOR/001A IIIB P3.5554 > 67 = 67 < 1 5 1
P3.5556 > 59.7 = 59.7 < 1 1 1 >60.55 60.55 5.01 <1
ROD P3.5555 > 54.8 = 54.8 < 1 1 1
P3.5557 > 60.7 = 60.7 < 1 1 1 >60.55 60.55 5.01 <1
WOR/003/4 IIIB P3.5554 > 125 > 125 X 1 1 1
P3.5556 > 164 = 164 < 1 0 1 >168.00 168.00 5.66 <1
ROD P3.5555 > 125 > 125 X 1 1 1
P3.5557 > 172 = 172 < 1 15 1 >168.00 168.00 5.66 <1
WOR/003/4B IIIB P3.5554 > 125 > 125 X 1 6 1
P3.5556 > 138 = 138 < 1 6 1 >136.00 136.00 2.83 <1
ROD P3.5555 > 125 > 125 X 1 7 1
P3.5557 > 134 = 134 < 1 10 1 >136.00 136.00 2.83 <1
BOE/BIRG587 IIIB P3.5544 = 0.027 > 4 > 148 121 1
 = Nevirapine P3.5546 = 0.0242 > 4 > 165 136 1
P3.5549 = 0.028 > 4 > 143 119 1
P3.5551 = 0.0297 > 4 > 135 112 1 0.027 0.002 >4.00 >147
ROD > 4 > 4 X 1 0 1 >4.00 >4.00 X1
CLO/3TC IIIB P3.5546 = 0.423 > 20 > 47 93 1
 =Lamivudine P3.5551 = 1.36 > 20 > 15 81 1 0.89 0.66 >20.00 >22
ROD P3.5547 = 1.75 > 20 > 11 96 1
P3.5552 = 5.37 > 20 > 4 97 1 3.56 2.56 >20.00 >6
DDN/AZT IIIB P3.5544 = 0.00193 > 25 > 12948 90 1
 =azidothymidine, P3.5546 = 0.00165 > 25 > 15110 88 1
zidovudine, P3.5549 = 0.00193 > 25 > 12979 80 1
retrovir© P3.5551 = 0.00189 > 25 > 13242 88 1 0.0019 0.0001 >25.00 >13514
ROD P3.5545 = 0.00187 > 25 > 13386 94 1
P3.5547 = 0.00162 > 25 > 15479 97 1
P3.5550 = 0.00132 > 25 > 18955 91 1
P3.5552 = 0.00168 > 25 > 14857 91 1 0.0016 0.0002 >25.00 >15408
DDN/DDI IIIB P3.5544 = 2 > 50 > 25 104 1
 = dideoxyinosine, P3.5549 = 3.12 > 50 > 16 115 1 2.56 0.79 >50.00 >20
didanosine ROD P3.5545 = 1.92 > 50 > 26 100 1
P3.5550 = 2.62 > 50 > 19 116 1 2.27 0.49 >50.00 >22
Table 2: Antiviral study of Garcinia kola extracts (1:1 methylene chloride/methanol-methanol, 1:1 methylene 
chloride/methanol-hexane, and MTB) versus controls (Nevirapine, Lamivudine, Azidothymidine, and 
Dideoxyinosine)  
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Graph 7: The results of surface charge through Zeta potential measurement 
 
Zeta potential measurement provides detailed information about the cause of 
dispersion, aggregation or flocculation which can be used to improve the formulation 
of dispersions, emulsions and or suspensions.  Results indicate a fairly consistent and, 
as compared to bare DPPC liposomes, negative surface charge for seven days in 
storage. The negative charge indicates that more phosphate head groups are exposed 
on the surface of the liposome as compared to that of the blank DPPC liposome (not 
shown), with a Zeta potential at -0.5mV.  This reveals that garcinol may strongly 
interact with the phosphate head groups of DPPC, perhaps exposing the negatively 
charged phosphate groups to the surface and an average of -14 mV for day 3 to 7 
indicating an incipient instability of the DPPC-containing liposomes.  
4.5.2 Differential light scattering (DLS) results 
DLS was used as a non-destructive method to characterize the size and size 
distribution of the garcinol liposomes in solution, in this case a biological buffer, 
(potassium phosphate buffer, pH 7.4). The results from DLS analysis of particle size 
are shown in Graph 8. The results suggest that Brownian motion (diffusion constant) 
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Graph 8: Garcinol particle size results 
of the liposomes in solution causes the laser to scatter at different intensities. The 
intensity fluctuation produces the velocity of the Brownian motion resulting in the 
calculation of the particle size which is related to the hydrodynamic radius. Results 
indicate an increase in the liposome size over seven days. Results also indicate 
garcinol liposome is stable the first three days.  At day five, aggregation starts to 
occur.  
 
 
Next, the result in Graph 9 summarizes the Polydispersity index (PDI) of the 
garcinol liposomes.  PDI takes into account the difference in size of the garcinol 
liposomes in solution, or distribution profile.  The average PDI of the garcinol 
liposomes over a period of seven days was 0.024.  There was also an increase in PDI 
over the seven days. The PDI results are consistent with the particle size data 
suggesting stability is enhanced the first three days at lower PDI.  This lower PDI 
value means that there was a relatively small particle size distribution and 
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Graph 9: Garcinol Polydispersity index results 
homogenous liposomal formulations and that the liposomes in solution were relatively 
stable over the course of the experiment. 
 
 
4.5.3 Nano-Differential Scanning Calorimetry (nano-DSC) results  
 DSC measures the transition temperature of the polymer in comparison to the 
polymer with garcinol. Results from the nano-DSC study are in Graph 10. 
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Graph 10: Results of phase transitions through DSC measurements of blank DPPC liposomes and DPPC garcinol 
liposomes 
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Results from Graph 10 indicate an ideal exothermic reaction with the blank 
DPPC. An important characteristic of transition temperature depends on molecular 
weight. The transition temperature of DPPC is 43.3 
○
C and molecular weight is 
734.039 g/mol whereas the molecular weight of garcinol is 602.8 g/mol. Because of 
this, results show a slight polymer degradation with a lower transition temperature 
(41.6
○
C) when garcinol is added to the DPPC liposomes. A slightly higher polymer 
being combined with a smaller molecular weight API, leads to a lower transition 
temperature for the garcinol formulation.  
4.5.4 Nuclear magnetic resonance (
1H
NMR and 
31
P-NMR) results  
The results in Graph 11 shows a proton NMR spectrum of Garcinol and 
Hexane, overlaid. This 
1H
NMR spectrum was conducted in order to determine the 
structure of both Garcinol and hexane extract as well as to see if they overlap.  Results 
indicate that although there are areas of the same hydrogen 1 nuclei within both 
extracts, the structures does not overlap so we can conclude that garcinol is not found 
within the hexane extract.  A complete chemical shift analysis of garcinol as compared 
to that of guttiferone F as stated in Fuller et al, shows that both compounds are 
relatively the same compounds called by different names as in Table 3. 
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The results in Graph 12 show a shielding of the phosphate nuclei of the 
garcinol liposome phospholipids, causing a slight change in transition temperature 
with a large tail.  Based upon the NMR data, the orientation of the blank liposome 
phosphate head groups are saturated within the bilayer of the liposome, whereas the 
split NMR peak suggests orientation at the surface of the bilayer. With these 
interactions, results remain consistent with Zeta potential and DSC showing an issue 
with stability of the formulation. 
 
Atom 
Chemical 
Shift (Δ) 
Chemical 
Shift (Δ)   
Position 
Guttiferone 
F Garcinol Difference 
6 1.49 1.46 0.03 
7 2.24 2.22 0.02 
7 2.04 2.00 0.04 
12 7.19 7.16 0.03 
15 6.68 6.57 0.11 
16 6.96 6.94 0.02 
17 2.71 2.68 0.03 
18 5.03 5.00 0.03 
20 1.73 1.70 0.03 
21 1.69 1.66 0.03 
22 1.15 1.12 0.03 
23 0.99 0.96 0.03 
24 2.02 2.03 -0.01 
25 4.87 4.83 0.04 
27 1.65 1.62 0.03 
28 1.49 1.47 0.02 
32 4.45 4.43 0.02 
33 1.58 1.55 0.03 
34 2.01 2.00 0.01 
35 5.03 5.00 0.03 
37 1.65 1.62 0.03 
38 1.57 1.55 0.02 
Table 3: 1HNMR chemical shift comparison of Garcinol and Fuller et al. 1999 Guttiferone F 
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Graph 12: Phosphorus NMR results of: (a) blank DPPC liposomes versus (b) garcinol DPPC liposome  
 
 
 
 
4.5.5 Formulation study 
 
In order to select the appropriate biological buffer for producing DPPC 
(b) Garcinol with DPPC 
(a) Blank DPPC 
Graph 11: 1HNMR spectrum of garcinol in red and hexane extract in black. 
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Figure 19:  137 mM Phosphate buffer solution initial. 
liposomes wherein garcinol would be stable, an HPLC stability study was conducted 
using garcinol in the presence of various biological buffers. This was conducted in 
order to select the best, non degrading buffer solution that garcinol would be stable in. 
The biological buffers used were: 137 mM phosphate buffer saline (PBS); 0.9% 
sodium chloride (NaCl); 5 mM sodium phosphate; 5 mM sodium chloride; 5 mM Tris 
(hydroxymethyl aminomethane); 5 mM sodium citrate; and 50 mM potassium 
phosphate (PPB) all at pH=7.4 while using the previously developed acetonitrile:water 
isocratic HPLC method for analysis. The HPLC chromatograms for each buffer 
system were as shown in Figure 19 to Figure 30. 
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Figure 20:  137 mM Phosphate buffer solution 19 hours. 
Figure 21:  137 mM Phosphate buffer solution 44 hours. 
Figure 22: 5mM  Sodium chloride initial. 
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Figure 24: 5 mM Tris initial. 
 
 
 
 
 
 
 
 
Figure 23: 5 mM Sodium chloride 31 hours. 
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Figure 25: 5 mM Tris 31 hours. 
Figure 26: 5 mM Sodium citrate initial. 
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Figure 27: 5 mM Sodium citrate 32 hours. 
Figure 28: 50 mM Potassium phosphate. 
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Figure 29: 50 mM Potassium phosphate 85 hours. 
 
 
  
 
 
 
 
 
Results in Figure 19 to Figure 29 show the injection of garcinol has a retention time of 
roughly 12.5 minutes. However, a number of degradants increased in size and were 
observed in the various buffer systems at about 7-9 minutes.  The concentrations also 
increased over time in several buffer systems.  Accordingly, potassium phosphate 
buffer solution was selected as the suitable liposome hydration medium for 
formulating garcinol in DPPC liposomes. 
Graph 5: Garcinol calibration curve 
Figure 50: UPLC fragment patter of  garcinol in PBS  
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The results of liposomal garcinol formulation are summarized in Graph 13 and 14 
below. 
 
 
 
 
Graph 13: Garcinol calibration curve with 50 mM Potassium Phosphate Buffer solution.  
Figure 33: Garcinol in PPB solution at various concentrations  
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Graph 14: Garcinol dialysis release study.   
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Graph 15 shows the garcinol HPLC calibration curve indicating a 97.26% linear trend 
line of concentration versus area under the curve.  In order to study the release of the 
garcinol formulation, a dialysis study was conducted as seen in Graph 14. Over the 24  
 
hour period, there was an increasing trend in concentration of the dialysis study.  
Garcinol released over time during the 24 hours was proportional to time. In the 
dissolution study, results in graph 15 indicate a fast release follow by a sharp (65%) 
drop in concentration after 4 hrs, perhaps due to saturation and precipitation of 
garcinol in solution. Given the high affinity of garcinol for DPPC lipid, a significant 
amount of garcinol might still be present in the bilayers.  
 
 
 
 
 
 
Graph 15: Garcinol dissolution release study.  
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CHAPTER 5 
 
CONCLUSION 
In this research, Garcinia kola was extracted using two different extraction 
techniques: liquid-liquid (same as solvent-solvent, S-S) and supercritical fluid 
extraction (SFE). Both techniques have their advantages and disadvantages. The 
extracts from each technique were subjected to analysis in order to isolate, identify 
and formulate garcinol, a reported antiviral compound present in related plants.  
Garcinia extracts were also assayed for antiviral activity which was not observed in 
vitro.  SFE extracts chemical compounds from Garcinia kola seeds using carbon 
dioxide instead of organic solvent as in HPLC.  In the SFE technique, three different 
modifiers were used (IPA, EtOH, MeOH) and in the S-S techniques, methanol, MTB, 
Sephadex, hexane, ethyl acetate and chloroform were used. Both extraction techniques 
were compared and analyzed by HPLC, UPC
2 
coupled to Q-Tof MS and compared 
using statistical analysis via PCA. PCA and dendrograms were used as visual aids to 
understand the different groupings, relevant use data, and understanding of the 
extraction coverage. Results indicated no presence of garcinol in any extract. The 
results indicated both techniques relatively extracted the same percent of extracts, 
50.40% and 55.49% respectfully.  In addition, 26.6% of the abundant mass features 
were extracted in both the SFE and S-S extracts meaning they overlapped in the 
compounds extracted. Both techniques serve as a means for complete chemical 
profiling of compounds. The compound of interest garcinol, was fragmented in a 
collision cell and that result yield structural information of four fragmented ions.  
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Although garcinol was not present in both the extraction techniques mentioned 
above, the aim of this research was to formulate an antiviral compound. garcinol, 
available commercially and found in other Garcinia spp., was used as a reference 
standard for comparative means.  Based upon the methods and techniques employed, 
it was determined that garcinol was not isolated from Garcinia kola in detectable 
amounts. Garcinol was used as a model compound for a representative liposomal 
formulation which was prepared and characterized. Preformulation experiments were 
conducted in order to identify an appropriate physiological buffer for preparing the 
liposomes, as it was found that garcinol was unstable in several representative buffer 
systems as well as release studies. 
Garcinol liposome were made using DPPC which is widely used to study 
liposomes.  
H
NMR and 
31
P-NMR analysis were performed for particle size separation 
as well as to observe the amount of hydrogen and phosphorus, in the garcinol 
compound. The proton NMR confirmed that garcinol and guttiferone F is relatively 
the same compound and both names are used interchangeable.  Phosphorous NMR 
observed any shielding effect of the garcinol liposomes.  Nano-DSC studies were 
performed for the transition temperature of the liposome lipid component (DPPC) 
blank and to predict the transition temperature of the garcinol liposomes. Results 
indicated a lower transition temperature in the garcinol-DPPC formulation.  DLS 
studies were performed in order to characterize the size and size distribution of the 
garcinol-DPPC liposome. The results indicate a uniform shape after sonication as well 
as an increase in size over time (7 days) which could be an indicator of stability issue.  
Zeta potential was conducted for the characterization of the surface charge of the 
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vesicles. The results showed that garcinol had a strong interaction with the phosphate 
head groups in the DPPC vesicles which may cause stability issues of the garcinol 
formulation. Both dialysis and dissolution study show garcinol was released in the 
DPPC liposome although in very small quantities.  
In conclusion, most of the applied techniques mentioned above including SFE, 
nano-DSC, UPC
2
 coupled to Q-Tof MS, 
31
P-NMR and liposomal formulation have not 
previously been performed on Garcinia kola preparations or garcinol.  This research is 
original, innovative and multidimensional.  Although Garcinia kola fractions did not 
inhibit HIV virus as compared to the controls, the techniques used in this research is 
trendsetting in the investigation of antiviral compounds found in Garcinia kola. 
Further investigation (structural elucidation for example) is necessary in order to 
identify the exact compound that corresponds with the common mass mentioned 
above. In addition, analyzing the mass of the compound in positive mode would also 
be useful in a more complex analysis.  Overall, both extraction techniques are 
complementary and may be necessary to achieve a comprehensive profile of the 
constituents found within Garcinia kola nuts and other natural products. Another 
future study suggestion includes further separating the extract in the S-S technique as 
well as the modified in the SFE technique which contained the largest number of 
detectable compounds and applying statistical analysis.  Lastly, isolating other 
biological activities in those extracts including antibacterial and or antifungal would 
show the diversity of this plant natural product.  With Garcinia kola, the possibilities 
are endless. 
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